Morning Overview on MSN

A new genomic test could spare two-thirds of high-risk breast cancer patients from chemotherapy entirely, per ASCO 2026 results

Thousands of women diagnosed with high-risk, estrogen-receptor-positive breast cancer may no longer need chemotherapy, ...
Becker's ASC

Clinical Genomics launches blood-based colorectal cancer test: 5 things to know

Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...

Many women with breast cancer could avoid chemotherapy – what you need to know about the genetic test

A new DNA test could spare millions of breast cancer patients from chemotherapy. We answer your questions about what it means ...
Business Wire

Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their PREDAPT clinical trial ...

Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

This Personalized Cancer Test Changed The Course Of My Treatment

It was this oncologist who had a very different recommendation: Try the Oncotype DX Breast Recurrence Score® test, a ...
Business Wire

Arima Genomics Expands Executive Team With Three Strategic Hires to Advance Clinical Applications of 3D Genomics

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today ...